The Language of Medication-Taking

Abstract

Medical Writings: Lingua Medica6 June 2000The Language of Medication-TakingJohn F. Steiner, MD, MPH and Mark A. Earnest, MDJohn F. Steiner, MD, MPHDrs. Steiner and Earnest: University of Colorado Health Sciences Center; Denver, CO 80262 and Mark A. Earnest, MDDrs. Steiner and Earnest: University of Colorado Health Sciences Center; Denver, CO 80262Author, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-132-11-200006060-00026 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Over the past 50 years, periods of intensive clinical and research interest in medication-taking have coincided with breakthroughs in drug development, such as antibiotics for infectious diseases in the 1950s (1-3), medications for hypertension in the 1960s and 1970s (4, 5), and highly active antiretroviral therapy for HIV infection in the 1990s (6-10). Hundreds of studies have found that only 50% to 60% of patients consume their medications for chronic diseases as prescribed (5), yet intensive, multimodal interventions often only marginally improve medication-taking or therapeutic outcomes (11, 12). Because medication-taking remains a clinically important problem despite 50 years of study, ...References1. Dixon WM, Stradling P, Wootton ID. Outpatient PAS therapy. Lancet. 1957;2:871-2. CrossrefGoogle Scholar2. Pitman ER, Benzier EE, Katz M. Clinic experience with a urine PAS test. Diseases of the Chest. 1959;36:1-2. CrossrefMedlineGoogle Scholar3. Markowitz M. Eradication of rheumatic fever: an unfulfilled hope. Circulation. 1970;41:1077-84. CrossrefMedlineGoogle Scholar4. Sackett DL, Haynes RB, Gibson ES, Hackett BC, Taylor DW, Roberts RS, et al . Randomised clinical trial of strategies for improving medication compliance in primary hypertension. Lancet. 1975;1:1205-7. CrossrefMedlineGoogle Scholar5. Sackett DL, Snow JC. The magnitude of compliance and noncompliance.. In: Haynes RB, Sackett DL, Taylor DW, eds. Compliance in Health Care. Baltimore: Johns Hopkins Univ Pr; 1979:11-22. Google Scholar6. Wainberg MA, Friedland G. Public health implications of antiretroviral therapy and HIV drug resistance. JAMA. 1998;279:1977-83. CrossrefMedlineGoogle Scholar7. Altice FL, Friedland GH. The era of adherence to HIV therapy [Editorial]. Ann Intern Med. 1998;129:503-5. LinkGoogle Scholar8. Paterson D, Swindells S, Mohr J, Brester M, Vergis E, Squier C, et al. How much adherence is enough? A prospective study of adherence to protease inhibitor therapy using MEMSCaps [Abstract]. In: Program and Abstracts of the Sixth Conference on Retroviruses and Opportunistic Infections. February 1999. Google Scholar9. Stone VE, Clarke J, Lovell J, Steger KA, Hirschhorn LR, Boswell S, et al . HIV/AIDS patients' perspectives on adhering to regimens containing protease inhibitors. J Gen Intern Med. 1998;13:586-93. CrossrefMedlineGoogle Scholar10. Smith MY, Rapkin BD, Morrison A, Kammerman S. Zidovudine adherence in persons with AIDS. The relation of patient beliefs about medication to self-termination of therapy. J Gen Intern Med. 1997;12:216-23. MedlineGoogle Scholar11. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomised trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996;348:383-6. CrossrefMedlineGoogle Scholar12. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care. 1998;36:1138-61. CrossrefMedlineGoogle Scholar13. Lerner BH, Gulick RM, Dubler NN. Rethinking nonadherence: historical perspectives on triple-drug therapy for HIV disease. Ann Intern Med. 1998;129:573-8. LinkGoogle Scholar14. Sackett DL. Introduction.. In: Sackett DL, Haynes RB, eds. Compliance with Therapeutic Regimens. Baltimore: Johns Hopkins Univ Pr; 1976:1-6. Google Scholar15. Haynes RB, Sackett DL. Appendix 1: Annotated bibliography.. In: Sackett DL, Haynes RB, eds. Compliance with Therapeutic Regimens. Baltimore: Johns Hopkins Univ Pr; 1976:193-279. Google Scholar16. Jenkins BW. Are patients true to t.i.d. and q.i.d. doses? General Practice. 1954;9:66-9. Google Scholar17. Prickman LE, Koelsche GA, Berkman JM, Carryer HM, Peters GA, Henderson LL. Does the executive health program meet its objective? Follow-up study of examinations of 231 management executives. JAMA. 1958;167:1451-5. CrossrefMedlineGoogle Scholar18. Feinstein AR. On white-coat effects and the electronic monitoring of compliance [Editorial]. Arch Intern Med. 1990;150:1377-8. CrossrefMedlineGoogle Scholar19. Milgrom H, Bender B, Ackerson L, Bowry P, Smith B, Rand C. Noncompliance and treatment failure in children with asthma. J Allergy Clin Immunol. 1996;98 6 Pt 1 1051-7. CrossrefMedlineGoogle Scholar20. Arluke A. Judging drugs: patients' conceptions of therapeutic efficacy in the treatment of arthritis. Hum Organ. 1980;39:84-7. CrossrefMedlineGoogle Scholar21. Conrad P. The meaning of medications: another look at compliance. Soc Sci Med. 1985;20:29-37. CrossrefMedlineGoogle Scholar22. Leventhal H, Cameron L. Behavioral theories and the problem of compliance. Patient Education and Counseling. 1987;10:117-38. CrossrefGoogle Scholar23. Trostle JA. Medication compliance as an ideology. Soc Sci Med. 1988;27:1299-308. CrossrefMedlineGoogle Scholar24. Chaulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis: Consensus Statement of the Public Health Tuberculosis Guidelines Panel. JAMA. 1998;279:943-8. CrossrefMedlineGoogle Scholar25. Temple R. Dose-response and registration of new drugs.. In: Lasagna L, Erill S, Naranjo CA, eds. Dose-Response Relationships in Clinical Pharmacology. Amsterdam: Elsevier; 1989:145-70. Google Scholar26. Materson BJ, Oster JR, Michael UF, Bolton SM, Burton ZC, Stambaugh JE, et al . Dose response to chlorthalidone in patients with mild hypertension. Efficacy of a lower dose. Clin Pharmacol Ther. 1978;24:192-8. CrossrefMedlineGoogle Scholar27. Norrby SR. Short-term treatment of uncomplicated lower urinary tract infections in women. Rev Infect Dis. 1990;12:458-67. CrossrefMedlineGoogle Scholar28. Carleton RA. Dichotomous disservice? Ann Intern Med. 1997;126:589-91. LinkGoogle Scholar29. Donovan JL. Patient decision making. The missing ingredient in compliance research. Int J Technol Assess Health Care. 1995;11:443-55. CrossrefMedlineGoogle Scholar30. Weintraub M. A different view of patient compliance in the elderly.. In: Vestal RE, eds. Drug Treatment in the Elderly. Boston: ADIS Health Science Pr; 1984:43-50. Google Scholar31. Steiner JF, Fihn SD, Blair B, Inui TS. Appropriate reductions in compliance among well-controlled hypertensive patients. J Clin Epidemiol. 1991;44:1361-71. CrossrefMedlineGoogle Scholar32. Inui TS, Carter WB, Pecoraro RE. Screening for noncompliance among patients with hypertension: is self-report the best available measure? Med Care. 1981;19:1061-4. CrossrefMedlineGoogle Scholar33. Wagner EH, Truesdale RA, Warner JT. Compliance, treatment practices and blood pressure control: community survey findings. J Chronic Dis. 1981;34:519-25. CrossrefMedlineGoogle Scholar34. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24:67-74. CrossrefMedlineGoogle Scholar35. Urquhart J. The electronic medication event monitor. Lessons for pharmacotherapy. Clin Pharmacokinet. 1997;32:345-56. CrossrefMedlineGoogle Scholar36. Graham DY, Lew GM, Malaty HM, Evans DG, Evans DJ, Klein PD, et al . Factors influencing the eradication of Helicobacter pylori with triple therapy. Gastroenterology. 1992;102:493-6. CrossrefMedlineGoogle Scholar37. Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. Is this patient taking the treatment as prescribed? JAMA. 1993;269:2779-81. CrossrefMedlineGoogle Scholar38. Kravitz RL, Hayes RD, Sherbourne CD, DiMatteo MR, Rogers WH, Ordway L, et al . Recall of recommendations and adherence to advice among patients with chronic medical conditions. Arch Intern Med. 1993;153:1869-78. CrossrefMedlineGoogle Scholar39. Steele DJ, Jackson TC, Gutmann MC. Have you been taking your pills? The adherence-monitoring sequence in the medical interview. J Fam Pract. 1990;30:294-9. MedlineGoogle Scholar40. Cramer JA, Scheyer RD, Mattson RH. Compliance declines between clinic visits. Arch Intern Med. 1990;150:1509-10. CrossrefMedlineGoogle Scholar41. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150:1881-4. CrossrefMedlineGoogle Scholar42. Kruse W, Weber E. Dynamics of drug regimen compliance—its assessment by microprocessor-based monitoring. Eur J Clin Pharmacol. 1990;38:561-5. CrossrefMedlineGoogle Scholar43. Mawhinney H, Spector SL, Kinsman RA, Siegel SC, Rachelefsky GS, Katz RM, et al . Compliance in clinical trials of two nonbronchodilator, antiasthma medications. Ann Allergy. 1991;66:294-9. MedlineGoogle Scholar44. Kruse W, Rampmaier J, Ullrich G, Weber E. Patterns of drug compliance with medications to be taken once and twice daily assessed by continuous electronic monitoring in primary care. Int J Clin Pharmacol Ther. 1994;32:452-7. MedlineGoogle Scholar45. Earnest MA, Steiner JF. Patterns of adherence with oxygen therapy in COPD [Abstract]. J Gen Intern Med. 1999;14 Suppl 2 26. Google Scholar46. Eddy DM. Clinical decision making: from theory to practice. Designing a practice policy. Standards, guidelines, and options. JAMA. 1990;263:3077, 3081, 3084. MedlineGoogle Scholar47. Nides MA, Tashkin DP, Simmons MS, Wise RA, Li VC, Rand CS. Improving inhaler adherence in a clinical trial through the use of the nebulizer chronolog. Chest. 1993;104:501-7. CrossrefMedlineGoogle Scholar48. Sheiner LB, Rubin DB. Intention-to-treat analysis and the goals of clinical trials. Clin Pharmacol Ther. 1995;57:6-15

Keywords

Affiliated Institutions

• University of Colorado Health US
• Denver School of Nursing US

Related Publications